MedPath

Ergin, Firat

🇸🇪Sweden
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

1

Active:0
Completed:1

Trial Phases

0 Phases

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Is Neutrophil to Lymphocyte Ratio a Prognostic Factor of Sepsis in Newborns With Operated Congenital Heart Disease

Completed
Conditions
Sepsis Newborn
First Posted Date
2019-04-22
Last Posted Date
2019-04-22
Lead Sponsor
Firat Ergin
Target Recruit Count
60
Registration Number
NCT03923543

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.